CONDENSED STATEMENT OF STOCKHOLDERS' EQUITY (Parenthetical) - USD ($)	3 Months Ended
Jun. 30, 2020	Mar. 31, 2019
Statement of Stockholders' Equity [Abstract]
Cost of issuance of common stock, preferred stock and warrants	$ 616,143	$ 40,000
Warrants, fair value	$ 370,666
Discount of issuance of common stock, preferred stock and warrants for clinical trial funding commitment		$ 235,640

Discount of Issuance of Common Stock, Preferred Stock and Warrants for Clinical Trial Funding Commitment

No definition available.

Name:	crdf_DiscountofIssuanceofCommonStockPreferredStockandWarrantsforClinicalTrialFundingCommitment
Namespace Prefix:	crdf_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration